|3 Months Ended|
Mar. 31, 2022
NOTE 10 – SHAREHOLDERS’ EQUITY
On May 24, 2021, the Board of Directors authorized a stock repurchase program to purchase up to $5.0 million of the currently outstanding shares of the Company’s common stock, over a period of 12 months through open market purchases, in compliance with Rule 10b-18 under the Securities Exchange Act of 1934. On January 18, 2022, the Board of Directors authorized a $2.0 million increase to the stock repurchase program, to a total of $7.0 million. On February 2, 2022, the Board of Directors authorized an additional $1.5 million increase to the stock repurchase, to a total of $8.5 million. During the three months ended March 31, 2022, the Company repurchased shares of common stock at an average price per share of $, for a total price of $3.8 million under this program. In total, the Company has repurchased shares of common stock at an average of $per share, for a total price of $8.5 million, under this program.
During the three months ended March 31, 2021, the Company repurchased shares of common stock at an average price of $ per share, for a total price of $ 3.0 million.
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef